慢性粒-单核细胞白血病的基因组决定因素
研究对150例慢性粒-单核细胞白血病(CMML)患者进行全外显子及靶向二代测序,并与586例相关髓系肿瘤比较,发现CMML具有独特分子谱;多数患者(59%)携带TET2、SRSF2或ASXL1的祖先(优势/共优势)突变,而亚克隆层级与临床表型及结局相关,基于突变层级的分类可能与临床特征和预后强相关。
要点
- 59%的CMML患者携带涉及TET2、SRSF2或ASXL1基因的祖先(优势/共优势)突变。
- 疾病进展与获得双等位TET2突变、RAS家族或剪接体基因突变的新扩增克隆相关。
- 发育异常特征与MDS常见突变(如SF3B1和U2AF1)相关。
核心结论
- 基于祖先和亚克隆突变事件层级的CMML分类可能与临床特征和预后强相关。
研究设计与样本
- 研究对150例具有可靠临床和分子注释的CMML患者进行全外显子组和靶向二代测序,并在横断面及系列时间点评估。
- 为识别CMML独特分子病变,将其与586例相关髓系肿瘤(包括幼年型粒-单核细胞白血病、骨髓增生异常综合征(MDS)和原发性单核细胞急性髓系白血病)进行比较。
主要发现
- 尽管病理形态学特征相似,CMML与相关髓系肿瘤仍可区分出不同的分子谱。
- 在CMML中,某些通路的突变与临床分类相关,例如增殖性 vs 发育异常特征。
- 大多数CMML患者(59%)具有涉及TET2、SRSF2或ASXL1基因的祖先(优势/共优势)突变。
- 继发性亚克隆层级与临床表型或结局相关,例如进展与获得携带双等位TET2突变或RAS家族或剪接体基因突变的新扩增克隆相关。
- 发育异常特征与MDS中常见突变(例如SF3B1和U2AF1)相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The biology, clinical phenotype and progression rate of chronic myelomonocytic leukemia (CMML) are highly variable due to diverse initiating and secondary clonal genetic events. To determine the effects of molecular features including clonal hierarchy in CMML, we studied whole-exome and targeted next-generation sequencing data from 150 patients with robust clinical and molecular annotation assessed cross-sectionally and at serial time points of disease evolution. To identify molecular lesions unique to CMML, we compared it to the related myeloid neoplasms (N=586), including juvenile myelomonocytic leukemia, myelodysplastic syndromes (MDS) and primary monocytic acute myeloid leukemia and discerned distinct molecular profiles despite similar pathomorphological features. Within CMML, mutations in certain pathways correlated with clinical classification, for example, proliferative vs dysplastic features. While most CMML patients (59%) had ancestral (dominant/co-dominant) mutations involving TET2, SRSF2 or ASXL1 genes, secondary subclonal hierarchy correlated with clinical phenotypes or outcomes. For example, progression was associated with acquisition of new expanding clones carrying biallelic TET2 mutations or RAS family, or spliceosomal gene mutations. In contrast, dysplastic features correlated with mutations usually encountered in MDS (for example, SF3B1 and U2AF1). Classification of CMML based on hierarchies of ancestral and subclonal mutational events may correlate strongly with clinical features and prognosis.
引用
- Patel BJ, Przychodzen B, Thota S, et al. Genomic determinants of chronic myelomonocytic leukemia. Leukemia. 2017. PMID: 28555081. doi:10.1038/leu.2017.164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。